The payout ratio is over 100% for this high-yield healthcare giant, but don't run for the hills just yet.
The smart money on Pfizer (NYSE: PFE) is sending a quieter signal than the financial press typically rewards: institutional ...
These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.
The Motley Fool on MSN
Is Pfizer's 6% Dividend Yield Safe? Here's What Investors Need to Know.
Pfizer's vaccine business cooled off, and it is on its back foot in the GLP-1 race, but don't count the drug giant out.
At 6.7%, Pfizer's dividend yield is exceptionally high, but whether it's sustainable is debatable.
In my March article, "Why Pfizer Remains A Strong Buy In 2026", I mainly discussed Pfizer's Q4 earnings ( PFE) and the ...
Why Johnson & Johnson’s stability, dividend growth, and buybacks may beat Pfizer’s low valuation and high yield. Read the ...
Two weeks ago, I said that one of my favorite stocks right now is Pfizer (PFE). The pharmaceutical giant is in the middle of ...
Pfizer (NYSE:PFE | PFE Price Prediction) at $25.75, Molina Healthcare (NYSE:MOH) at $186.80, and Halliburton (NYSE:HAL) at $41.29 trade at defensive, cash-generative valuations. Michael Burry ...
High-dividend stocks have long attracted investors seeking steady income. And amid the volatility and uncertainty of 2026, ...
Shares of Pfizer (NYSE: PFE) have fallen 55% from their late 2021 high. That decline highlights a material change in Wall Street's view of the pharmaceutical giant. And it has pushed the dividend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results